Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
about
Clinical management of regorafenib in the treatment of patients with advanced colorectal cancerChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsTransdermal fentanyl for pain due to chemoradiotherapy-induced oral mucositis in nasopharyngeal cancer patients: evaluating efficacy, safety, and improvement in quality of life.A Randomized Placebo- Controlled Double Blind Clinical Trial of Quercetin in the Prevention and Treatment of Chemotherapy-Induced Oral Mucositis."Coffee plus honey" versus "topical steroid" in the treatment of chemotherapy-induced oral mucositis: a randomised controlled trialAdverse event management of oral mucositis in patients with breast cancerPreventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species productionEffect of laser phototherapy in the prevention and treatment of chemo-induced mucositis in hamsters.Lack of a significant pharmacokinetic interaction between maraviroc and tacrolimus in allogeneic HSCT recipients.Use of Curcumin Mouthrinse in Radio-Chemotherapy Induced Oral Mucositis Patients: A Pilot Study.Jaw mobility changes in patients with upper aerodigestive tract cancer undergoing radiation therapy.Risk factors of radiation-induced acute esophagitis in non-small cell lung cancer patients treated with concomitant chemoradiotherapy.Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice.A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal CancerThe involvement of mast cells in the irinotecan-induced enteric neurons loss and reactive gliosis.Management of gastrointestinal mucositis due to cancer therapies in pediatric patients: results of a case series with SAMITAL(®).In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.The effect of eating sea cucumber jelly on Candida load in the oral cavity of elderly individuals in a nursing homeInnovative intraoral cooling device better tolerated and equally effective as ice cooling.Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma.New roles of serotonin and tachykinins in intestinal mucositis?The effect of a supersaturated calcium phosphate mouth rinse on the development of oral mucositis in head and neck cancer patients treated with (chemo)radiation: a single-center, randomized, prospective study of a calcium phosphate mouth rinse + staFentanyl pectin nasal spray for painful mucositis in head and neck cancers during intensity-modulated radiation therapy with or without chemotherapy.Nystatin and lidocaine pastilles for the local treatment of oral mucositis.Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.Side-Effects of Irinotecan (CPT-11), the Clinically Used Drug for Colon Cancer Therapy, Are Eliminated in Experimental Animals Treated with Latex Proteins from Calotropis procera (Apocynaceae).Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics.A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up.Chamomile infusion cryotherapy to prevent oral mucositis induced by chemotherapy: a pilot study.Measuring the Quality of Life among Head-and/or-Neck Cancer Patients with Oral Mucositis Using the Functional Assessment of Cancer Therapy-General in Jordan.Natural agents in the management of oral mucositis in cancer patients-systematic review
P2860
Q26821956-F57D98E3-61E7-48D4-AF74-F169B87936B4Q28079705-D5D4996B-9EC7-478C-ACF9-0C0DF5DBE8EEQ33632748-781EFD73-A8A8-402C-ACFC-2C61CB0A8264Q33667061-3091A878-D4A4-428E-B8B8-451A040E7795Q34116283-1B6C89D5-58B7-47CA-9E38-7427977A5282Q34403510-E70AAB48-3675-4B8C-83C4-3250A143560EQ34497892-6101F994-8C2C-4DAD-8806-3DF649E14C17Q34764711-4BF66F1F-2A56-4E32-A079-1B59A3B5853CQ35755674-AF4B9551-EEE9-49EB-BAF5-76DDDD51DDB9Q36077623-AFE03E1B-7B71-4F37-8EBD-0113298C924EQ36348219-83B7DC40-1F85-434D-9365-38D019ECEF70Q37607401-93B2EFDA-79F1-4B47-8273-AA5F2C073EDBQ37719409-78D058E2-EEB2-4B45-BF72-EEF43015B7DDQ38674714-6A55B74D-CF24-4115-ABBF-5A71D8CA2A1DQ38847554-0754474A-F3E9-4FAE-91AF-8F69A6A9CC6DQ39520846-5808E0B9-7CA7-4907-83DE-37C06C8D9589Q40264385-4A150B01-C05C-4005-B1D7-02CF0A7989EFQ41845327-B2B43CF7-0214-4A31-BE20-471E4A9C9F1FQ41991411-6EE9D73E-FFC0-47ED-AE91-9EA9B79955E7Q43245911-26F5E45C-6E1E-4466-88F6-99B07CD9F84EQ44993960-6B48260D-30DF-4E6B-8594-6107EFBBAADEQ44997024-74B350A8-2579-4BD0-9031-6BAA40933AD2Q47364748-2D3FF575-22F2-4E8F-B54C-F208D0305081Q47400944-79CDECC5-80D5-4E85-B304-3D213FBD9A0DQ47993911-ED5810CA-14FF-45D6-A63D-83FAAE9FB850Q51290587-A3224CC2-9A16-4D25-822C-835011B4EE32Q52362144-D7F3C73E-B121-44AB-9E95-0E77BF5C864AQ52560942-FFB594E5-0874-4BAE-8AFE-D71A49A0EE59Q53440587-BC0A5ED9-5BF0-46E5-81E6-435296BD0E40Q53607893-F6CE421E-2787-44EC-9407-A959E304E43FQ55352416-C173ED1A-3737-4D3B-A298-32279569F2B2Q57164934-BC290E76-DC68-4897-9B3A-1878FCC57662
P2860
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
@en
type
label
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
@en
prefLabel
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
@en
P2093
P2860
P356
P1433
P1476
Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines.
@en
P2093
D E Peterson
ESMO Guidelines Working Group
R-J Bensadoun
P2860
P304
P356
10.1093/ANNONC/MDR391
P478
22 Suppl 6
P577
2011-09-01T00:00:00Z